Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors

University of Manchester 2017. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. WO/2017/017469. [Patent].

Full text not available from this repository.


Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.

Item Type: Patent
Date Type: Publication
Status: Published
Schools: Biosciences
Publisher: WO Patent
Last Modified: 01 Jun 2018 15:13

Actions (repository staff only)

Edit Item Edit Item